Aker BioMarine will release the fourth quarter 2025 results on Thursday 12February 2026 at 07:00 CET.
At 09:00 CET on the same day, the management will host a webcast to presenttheresults. Following a presentation, there will be a Q&A session where writtenquestions can be submitted to ir@akerbiomarine.com.
The webcasted presentation will be in English. To join, please use the linkthatwill be available at www.akerbiomarine.com/investor.
A replay of the presentation and Q&A session will be made available soon afterthe presentation at the same web page.
For further information, please contact Christopher Robin Vinter, VP Strategic Finance & IRMobile: +47 911 60 820Email: christopher.vinter@akerbiomarine.com
About Aker BioMarineAker BioMarine is a leading human health and nutrition innovator that developskrill-derived products for consumer health and nutrition. Krill is a natural,powerful, and health-promoting source of nutrients from the pristine waters ofAntarctica, and Aker BioMarine has a unique position in its industry. Theingredient portfolio consists of Superba Krill Oil, Lysoveta, Revervia, andPL+,as well as the consumer brand, Kori Krill. The innovative approach alsoextendsinto the spin-offs AION (reduce and recycle plastic waste across industries)andUnderstory (a protein brand). Aker BioMarine is listed on the Oslo StockExchange (AKBM). More information is available at www.akerbiomarine.com.
https://newsweb.oslobors.no/message/665455